{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:51:27Z","timestamp":1790009487728,"version":"4.0.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> Free androgen index (FAI) and anti-Mullerian hormone (AMH) are independently associated with polycystic ovary syndrome (PCOS). This study aimed to describe the relationship between these two markers and health-related quality of life (HR-QoL) in women with PCOS.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This cross-sectional study consisted of 81 women in the Hull PCOS biobank, who fulfilled the Rotterdam consensus criteria for the diagnosis of PCOS. The primary outcome was to measure the various domains of the QoL in the modified polycystic ovary syndrome questionnaire (MPCOSQ).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Mean age of the study participants was 28 \u00b1 6.0 years, mean body mass index (BMI) 33.5 \u00b1 7.8 kg\/m<jats:sup>2<\/jats:sup>, mean FAI (6 \u00b1 5.5), free testosterone (2.99 \u00b1 0.75) and mean AMH (3.5 \u00b1 0.8 units). In linear regression analysis, the FAI was associated with overall mean MPCOSQ score (Beta = 0.53, <jats:italic>P<\/jats:italic>-value = 0.0002), and with depression (Beta = 0.45, <jats:italic>P<\/jats:italic>-value = 0.01), hirsutism (Beta = 0.99, <jats:italic>P<\/jats:italic>-value = 0.0002) and menstrual irregularity (Beta = 0.31, <jats:italic>P<\/jats:italic>-value = 0.04). However, with adjustment for age and BMI, FAI was only associated with the hirsutism domain (Beta = 0.94, <jats:italic>P<\/jats:italic>-value = 0.001) of the MPCOSQ. FAI was also associated with the weight domain (Beta = 0.63 <jats:italic>P<\/jats:italic>-value = 0.005) of MPCOSQ. However, AMH was not associated with the overall mean MPCOSQ score or with any of its domains.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> FAI but not AMH was associated with QoL in women with PCOS, and this effect was mediated by BMI.<\/jats:p>","DOI":"10.3389\/fphys.2021.652559","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:44:46Z","timestamp":1621838686000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Mohammed Altigani","family":"Abdalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfaan","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fendo.2019.00656","article-title":"Anti-Mullerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome.","volume":"10","author":"Abbara","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"B2","doi-asserted-by":"crossref","first-page":"851815","DOI":"10.1155\/2013\/851815","article-title":"Level of anxiety, depression, self-esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome.","volume":"2013","author":"Acmaz","year":"2013","journal-title":"Sci. World J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2017.00117","article-title":"The distribution of stroma and antral follicles differs between insulin-resistance and hyperandrogenism-related polycystic ovarian syndrome.","volume":"8","author":"Alviggi","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"B4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/cen.13858","article-title":"The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome.","volume":"90","author":"Amiri","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome.","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum. Reprod."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/humrep\/des199","article-title":"Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire.","volume":"27","author":"Bazarganipour","year":"2012","journal-title":"Hum. Reprod."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/01443615.2019.1587604","article-title":"AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.","volume":"39","author":"Calzada","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2265.2007.02742.x","article-title":"Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers.","volume":"66","author":"Ching","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/cen.13879","article-title":"Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome.","volume":"90","author":"Deshmukh","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.steroids.2011.12.008","article-title":"Mood and anxiety disorders in women with PCOS.","volume":"77","author":"Dokras","year":"2012","journal-title":"Steroids"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS.","volume":"101","author":"Dokras","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12958-017-0271-4","article-title":"Psychological stress is related to a decrease of serum Anti-Mullerian hormone level in infertile women.","volume":"15","author":"Dong","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1210\/jc.2003-030562","article-title":"Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.","volume":"88","author":"Elsenbruch","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1515\/cclm-2019-1059","article-title":"Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.","volume":"58","author":"Evliyaoglu","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil. Steril."},{"key":"B16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.rbmo.2010.04.032","article-title":"Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria.","volume":"21","author":"Guo","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jclinepi.2003.10.018","article-title":"Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.","volume":"57","author":"Guyatt","year":"2004","journal-title":"J. Clin. Epidemiol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00404-006-0173-8","article-title":"Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam\u2019s criteria and women whose only clinical signs are oligo\/anovulation or hirsutism.","volume":"274","author":"Hassa","year":"2006","journal-title":"Arch. Gynecol. Obstet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.beem.2006.03.009","article-title":"Pregnancy complications in PCOS.","volume":"20","author":"Homburg","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/humrep\/deh048","article-title":"The polycystic ovary syndrome health-related quality of life questionnaire (PCOSQ): a validation.","volume":"19","author":"Jones","year":"2004","journal-title":"Hum. Reprod."},{"key":"B22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-59745-108-6_4","article-title":"Pregnancy in polycystic ovary syndrome.","volume":"17","author":"Kamalanathan","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrendo.2011.97","article-title":"Reproductive endocrinology: androgens inversely related to depression in PCOS.","volume":"7","author":"Koch","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"B24","first-page":"669","article-title":"Differences in the psychological and hormonal presentation of lean and obese patients with polycystic ovary syndrome.","volume":"34","author":"Komarowska","year":"2013","journal-title":"Neuro. Endocrinol. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2265.2011.04122.x","article-title":"Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome.","volume":"75","author":"Livadas","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/humrep\/der418","article-title":"Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.","volume":"27","author":"Panidis","year":"2012","journal-title":"Hum. Reprod."},{"key":"B27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/09513590701536246","article-title":"Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.","volume":"23","author":"Pehlivanov","year":"2007","journal-title":"Gynecol. Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/09513590.2015.1009437","article-title":"Mood disorders and quality of life in polycystic ovary syndrome.","volume":"31","author":"Podfigurna-Stopa","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-7827-12-23","article-title":"Acne and PCOS are less frequent in women with Mayer-Rokitansky-Kuster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study.","volume":"12","author":"Rall","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0165-0327(02)00117-9","article-title":"Depression in women with polycystic ovary syndrome: clinical and biochemical correlates.","volume":"74","author":"Rasgon","year":"2003","journal-title":"J. Affect. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum. Reprod."},{"key":"B32","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1038\/s41598-018-22176-1","article-title":"Salivary and serum androgens with anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome.","volume":"8","author":"Sathyapalan","year":"2018","journal-title":"Sci. Rep."},{"key":"B33","first-page":"473","article-title":"Health-related quality of life in polycystic ovary syndrome patients: a systematic review.","volume":"13","author":"Taghavi","year":"2015","journal-title":"Iranian J. Reprod. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1367\/a04-130r.1","article-title":"Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life.","volume":"5","author":"Trent","year":"2005","journal-title":"Ambul. Pediatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s1083-3188(02)00205-x","article-title":"Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life.","volume":"16","author":"Trent","year":"2003","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1447-0756.2010.01478.x","article-title":"Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.","volume":"37","author":"Yilmaz","year":"2011","journal-title":"J. Obstet. Gynaecol. Res."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.652559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:44:54Z","timestamp":1621838694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.652559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":36,"alternative-id":["10.3389\/fphys.2021.652559"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.652559","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"article-number":"652559"}}